You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.


  • 'Frozen' bests Barbie as top pick
    NEW YORK – For the first time in more than a decade, Barbie has been frozen out of the top spot on the holiday wish lists of girls.
  • Apple value hits record $700 billion
    SAN FRANCISCO – Apple's market value surpassed $700 billion in Tuesday trading, an unprecedented milestone among U.S. companies. Shares backtracked in the afternoon, closing down $1.
  • Growth jumps a solid 3.9%
    WASHINGTON – The U.S. economy grew at a sturdy 3.
Washington Post
Keith Dunleavy, chief executive of Inovalon, says that ePASS is meant to guide, not replace, healthcare providers by suggesting questions relevant to each patient.

Walgreens unveils point of care

The next time a patient walks into a Walgreens clinic, the clinician may not be the only one assessing patients.

Soon, hundreds of Walgreens clinics will be equipped with new software that guides health-care providers through checkups – requiring them to ask certain questions or request particular lab tests depending on the patient’s history. The software, called ePASS, was developed by Inovalon, a IT firm in Bowie, Md., with about 3,000 employees worldwide.

Inovalon’s analytics churn through data from more than 100 million patients and uses predictive algorithms to suggest health conditions they might have. Inovalon and Walgreens announced in late January that clinicians may use ePASS to assess any patient whose records Walgreens has on file, expanding the number of patients Inovalon reaches. Previously, only patients whose health-plan providers had granted Inovalon access to their files would be assessed using ePASS.

Inovalon is one of many businesses managing and analyzing the large volumes of data stored in electronic health record systems to predict problems; others include Reston, Va.-based Altruista Health, which identifies high-risk patients for health insurance companies; Vitera, a Tampa, Fla., firm whose analytic software tracks tests and referrals; and New York startup AllazoHealth, which focuses on whether patients are taking their medication.

Before joining with Inovalon in September, Walgreens did not use any predictive software to help clinicians question patients, said Heather Helle, divisional vice president of Walgreens clinics.

Walgreens has been gradually setting the system up in clinics across the United States, beginning with Philadelphia.

“Being able to have the power of advanced analytics at the point of care, and being able to combine that with immunization and lab resources we have,” means clinicians have “as much information up front as possible when a patient checks in for assessment and is taken into the back room,” Helle said.

Upon arriving at a Walgreens clinic, patients sign in at a computer kiosk and their names are fed into a list on a clinician’s computer in an examination room. During the checkup, the software tailors questions to the patient’s history from health records, and to conditions the patient is likely to have, based on Inovalon’s assessment of millions of other patients.

The system also takes into account patients’ behavior – whether they are likely to get regular checkups and tests or if they avoid them, for instance – so clinicians can make a note to follow up if necessary.

As an example, the software might suggest that a clinician discuss ways to improve kidney function with a 70-year-old diabetic so the patient does not develop blindness, but that discussion might be optional for a healthy 25-year-old with a cold who gets regular checkups.

EPASS ultimately is meant to guide – not replace – health-care providers by suggesting questions relevant to individual patients, Inovalon chief executive Keith Dunleavy said. “If you had days to spend with this person and access to all their past care, you could deliver a similar” service.

At the end of the checkup, ePASS compiles a SOAP note – a “subjective, objective assessment and plan,” or a quick summary of the checkup and treatment – which is then transferred back into the patient’s electronic health records.

The predictive system can sometimes be stymied by gaps in health records, Dunleavy said.

If a patient’s primary-care provider has not recorded the results of a lab test, for instance, ePASS notifies the provider that certain data points are missing.

The more patients who come to Walgreens, the more data Inovalon’s software collects, gradually improving the algorithm’s predictive capability, Dunleavy said.